| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/06/2005 | EP1550469A1 Stable biodegradable, water absorbing gamma-polyglutamic acid hydrogel |
| 07/06/2005 | EP1550463A1 Preparation for facilitating site-specific gene conversion and preparation for gene therapy |
| 07/06/2005 | EP1550440A1 Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia |
| 07/06/2005 | EP1549669A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549663A2 Multifunctional polypeptides |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549352A2 Methods for delivery of nucleic acids |
| 07/06/2005 | EP1549350A1 Pharmaceutically active oligosaccharide conjugates |
| 07/06/2005 | EP1549349A1 Non-viral gene delivery system |
| 07/06/2005 | EP1549337A1 Glycosaminoglycan-dnase combination therapy |
| 07/06/2005 | EP1549332A2 Modified asialo-interferons and uses thereof |
| 07/06/2005 | EP1549327A1 Composition for treating hemorrhoids |
| 07/06/2005 | EP1549323A2 Conjugates comprising central nervous system active drug |
| 07/06/2005 | EP1549310A1 Gelled laxative compositions |
| 07/06/2005 | EP1549296A1 Sustained release formulations of metformin |
| 07/06/2005 | EP1549295A2 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 07/06/2005 | EP1549291A1 Injection formulation |
| 07/06/2005 | EP1549269A2 Cyclodextrin-based materials, compositions and uses related thereto |
| 07/06/2005 | EP1549253A2 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
| 07/06/2005 | EP1390370A4 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 07/06/2005 | EP1220662B1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 07/06/2005 | EP1162982B9 USE OF STABILISED OLIGONUCLEOTIDES FOR PREPARING A MEDICament WITH ANTITUMOUR ACTIVITY |
| 07/06/2005 | EP1140145B1 Novel exendin agonist formulations and methods of administration thereof |
| 07/06/2005 | EP1117379B1 Foamable formulation and foam |
| 07/06/2005 | CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 07/06/2005 | CN1636021A Preparation and use of solidified oils |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635912A Targeted delivery of drugs for the treatment of parasitic infections |
| 07/06/2005 | CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 07/06/2005 | CN1635910A Treatment and diagnosis of macrophage mediated disease |
| 07/06/2005 | CN1635909A Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635899A Stimulation of bone growth with thrombin peptide derivatives |
| 07/06/2005 | CN1635894A Dosage form for treatment of diabetes mellitus |
| 07/06/2005 | CN1635881A Liquid formulation of metformin |
| 07/06/2005 | CN1635879A Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
| 07/06/2005 | CN1635875A Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 07/06/2005 | CN1635874A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/06/2005 | CN1635873A Methods and apparatus for extrusion of vesicles at high pressure |
| 07/06/2005 | CN1635872A Proliposomal drug delivery system |
| 07/06/2005 | CN1635871A Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 07/06/2005 | CN1635870A Medicinal aerosol formulations |
| 07/06/2005 | CN1635864A Oligosaccharide aldonic acids and their topical use |
| 07/06/2005 | CN1635863A Systems, methods and apparatuses for manufacturing dosage forms |
| 07/06/2005 | CN1635832A Method for administering GLP-1 molecules |
| 07/06/2005 | CN1634969A Cholestrin derivative as nucleoside analog |
| 07/06/2005 | CN1634613A Plant source alcohol soluble protein and its preparation method |
| 07/06/2005 | CN1634593A Carbonized pollen and its application for preparing medicine to treat cancer |
| 07/06/2005 | CN1634592A Transdermal pharmaceutical and its preparation method |
| 07/06/2005 | CN1634591A Short peptide modified polylysine-polylactic copolymer nano particle and its preparation method and use |
| 07/06/2005 | CN1634590A Method for manufacturing chitosan capillary and application thereof |
| 07/06/2005 | CN1634589A Injection using invert sugar water solution as carrier |
| 07/06/2005 | CN1634588A Medicinal nano carbon microsphere and its application for preparing medicine to treat cancer |
| 07/06/2005 | CN1634576A Medicine composition for improving stability of human urine kininogenase |
| 07/06/2005 | CN1634133A Suspension of Fe#-[3]O#-[4] microparticle and iodized oil for treating liver and kidney tumor by embolizing and its preparation process |
| 07/06/2005 | CN1634129A Sustained release high calcium formulation and preparation process thereof |
| 07/06/2005 | CN1634123A Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method |
| 07/06/2005 | CN1634040A Indirubin phosphatide compound and its preparation method |
| 07/06/2005 | CN1633998A Volatile general anesthetic drug- propofol intravenous intralipid |
| 07/06/2005 | CN1633993A Polymer material pharmaceutical preparation capsule releasing under control of outer enviornment pH value |
| 07/06/2005 | CN1633990A Preparation method of liposome with high encapsulating rate to water soluble medicine |
| 07/06/2005 | CN1209355C Derivate of sweetsop lactone as well as preparation method and usage |
| 07/06/2005 | CN1209188C Dehydrating agent and method for dehydrating method of hydrate using the agent and dehydrated article obtained by the method |
| 07/06/2005 | CN1209167C Supersonic contrast medium and method for preparing supersonic contrast medium simultaneously as medicine and gene target carrier |
| 07/06/2005 | CN1209160C Skin-infiltrating film of Chinese traditional medicine for treating paralysis resulting from central nerve trauma and its preparation method |
| 07/06/2005 | CN1209108C Trans-dermal composition of anti-vomiting agent and preparation containing the same |
| 07/06/2005 | CN1209106C Use of ellagic acid as anti-pollution cosmetic agent |
| 07/06/2005 | CN1209105C Coronary artery skeleton medicinal coating for preventing restenosis of blood vessel |
| 07/06/2005 | CN1209103C Fenofibrate soft capsule and its preparation method |
| 07/06/2005 | CN1209098C Methods and devices for providing prolonged drug therapy |
| 07/06/2005 | CN1209091C 硬胶囊 Hard Capsules |
| 07/05/2005 | US6914225 Apparatus and methods for single sheet forming using induction heating |
| 07/05/2005 | US6914126 Crosslinking agent reacts with reactive pendant groups existing on the keratin molecules to produce biocompatible heterogenous proteinaceous networks crosslinked with the heterogenous crosslinker |
| 07/05/2005 | US6914121 Administering polyethylene glycol-luteinizing hormone releasing hormone (LHRH) analog conjugate having a polyethylene glycol (PEG) moiety covalently bound to a serine residue of LHRH analog hydrolysis to release |
| 07/05/2005 | US6914073 Multivitamin/multimineral optimized for cardiovascular health containing increased levels of Vitamin E; does not leach vitamin E |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6914055 Cancer therapeutic formulation having reduced toxicity comprising a galactomannan, and a chemotherapeutic agent |
| 07/05/2005 | US6914051 Penetrating antibiotic gel for soft tissue diseases |
| 07/05/2005 | US6914050 Stimulation of bone growth with thrombin peptide derivatives |
| 07/05/2005 | US6914048 Method for delivery of molecules to intracellular targets |
| 07/05/2005 | US6913932 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913915 PEG-modified uricase |
| 07/05/2005 | US6913903 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 07/05/2005 | US6913890 Preparing nucleotide sequence bovine serum albumin conjugates for use as diagnostic tools in genetic and biochemical analysis |
| 07/05/2005 | US6913779 Process for the preparation of accelerated release formulations using compressed fluids |
| 07/05/2005 | US6913764 Antibiotic(s) preparation with retarding active ingredient release |
| 07/05/2005 | US6913761 Sustained drug delivery |
| 07/05/2005 | US6913759 Gel composition and method for treatment of vaginal infections |
| 07/05/2005 | US6913748 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| 07/05/2005 | US6913746 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 07/05/2005 | CA2210041C Branched cyclodextrins and method for producing them |
| 07/05/2005 | CA2127463C Biodegradable polymers for cell transplantation |
| 07/05/2005 | CA2101101C Skin care compositions comprising a retinoid and an imidazole |
| 07/05/2005 | CA2093946C Methanediphosphonic acid formulations with ion exchangers |
| 06/30/2005 | WO2005059508A2 Cellular probes |
| 06/30/2005 | WO2005059129A2 Adapter for coupling a substance which is to be coupled to a cell surface |
| 06/30/2005 | WO2005059118A2 Stem cell targeting using magnetic particles |